Ads
related to: eli lilly weight loss drugFDA-Approved Treatment. Indication & Safety Summary with Warnings. A Lilly Medicine. Learn What is Zepbound™, How Does it Work, and If It's Right For You.
- Savings & Coverage
Find Out If You Qualify for
The Zepbound® Savings Card.
- Lilly Direct
Connect to Resources That May Help
Along Your Treatment Journey.
- Resources and Support
Resources to Guide You
On Your Zepbound® Journey.
- About Zepbound®
Learn What Zepbound® Is,
How it Works, and How It May Help.
- How to Use Zepbound®
See How to Use Zepbound® &
Read the Instructions for Use.
- Instructional Video
Watch & Learn: A Step-by-Step
Guide to Your Zepbound® Pen
- Savings & Coverage
A Prescription Option For Adults With Obesity, Discover How It May Help You. Access Patient Resources & Support Including Quick Start Guide & Savings Information.
Search results
Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Zepbound should be used with a reduced-calorie diet and increased physical activity.
Nov 8, 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Zepbound should be used with a reduced-calorie diet and increased physical activity.
Apr 28, 2022 · Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1. Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study. 63% of participants taking tirzepatide 15 mg achieved at least 20% body weight reductions as a key secondary endpoint. INDIANAPOLIS, April 28, 2022 ...
Jun 4, 2022 · In this 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight. (Supported by Eli Lilly;...
Oct 15, 2023 · In a co-primary endpoint, following the lead-in period, participants taking tirzepatide achieved an additional 21.1% mean weight loss. In a secondary endpoint, participants achieved a total mean weight loss of 26.6% (29.2 kg or 64.4 lb.) from study entry over 84 weeks.
Nov 8, 2023 · Blood sugar drug tirzepatide also leads to substantial weight loss in diabetes patients, Eli Lilly says. The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss,...
Ads
related to: eli lilly weight loss drugFDA-Approved Treatment. Indication & Safety Summary with Warnings. A Lilly Medicine. Learn What is Zepbound™, How Does it Work, and If It's Right For You.
A Prescription Option For Adults With Obesity, Discover How It May Help You. Access Patient Resources & Support Including Quick Start Guide & Savings Information.
